ADME investigations of novel therapeutic modalities: challenges and opportunities 2025
By integrating recent preclinical and clinical insights with advances in bioanalytical methods and mechanistic modeling, we present forward-looking perspectives on enabling more precise and effective dosing strategies for these complex modalities. Article.
Authors
- Richard Dambra (ORCID: https://orcid.org/0000-0001-8566-5199)
- Swen Seeland (ORCID: https://orcid.org/0000-0003-0863-2865)
- Elise Ishida (ORCID: https://orcid.org/0000-0003-0569-5094)
- Nicholas Krebs
- Hongbin Yu
- Ali Khalilimeybodi
- Minu Ravindra Pilvanker
- Gary Chan
Institutions
- NBE Therapeutics (Switzerland) (CH)
- Drug Discovery Laboratory (Norway) (NO)
Publication Details
- Journal
- Expert Opinion on Drug Metabolism & Toxicology
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1080/17425255.2026.2650189
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00